Ranolazine
Ranolazine extended-release tablets are indicated for the treatment of chronic angina. Ranolazine extended-release tablets may be used with beta-blockers, nitrates, calcium channel…
Medications Updated During May 2022, From Newest to Oldest, Page 33
ZERBAXA (Ceftolozane and Tazobactam)
ZERBAXA (ceftolozane and tazobactam) is a combination of ceftolozane, a cephalosporin antibacterial, and tazobactam, a beta-lactamase inhibitor, indicated for the treatment of the…
Tibsovo (Ivosidenib)
TIBSOVO is an isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for the treatment of acute myeloid leukemia (AML) with a susceptible IDH1 mutation as detected by an FDA-approved test…
EluRyng (Etonogestrel and Ethinyl Estradiol)
FOR VAGINAL USE ONLY. EluRyng(TM) is indicated for use by females of reproductive age to prevent pregnancy. EluRyng is an estrogen/progestin combination hormonal contraceptive (CHC)…
Metaxalone
Metaxalone is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomforts associated with acute, painful musculoskeletal conditions. The mode of…